advert
Angel News

Back to Homepage

19th April 2018 - 0 comments

Zelluna Immunotherapy appoints Arjan Roozen as CTO

Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, has announced the appointment of Arjan Roozen as chief technology officer (CTO). 

...

Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:

Name:

Email:

Comment:

Enter the characters in the image shown:



Back to Homepage